US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.695
  • +0.045+2.73%
Trading Jul 22 14:58 ET
11.48MMarket Cap-1948P/E (TTM)

Biorestorative Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.58%-2.32M
-8.75%-6.43M
-9.76%-1.77M
18.87%-1.18M
12.10%-1.1M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
-68.65%-1.25M
Net income from continuing operations
69.00%-2.22M
21.21%-10.42M
26.77%1.17M
37.16%-2.93M
68.08%-1.49M
-48.93%-7.17M
70.16%-13.22M
104.53%924.92K
-11.27%-4.66M
-15.08%-4.68M
Operating gains losses
-221.17%-1.73M
14.61%-4.57M
----
----
----
--1.42M
-133.06%-5.35M
----
----
----
Depreciation and amortization
8.54%42.71K
37.49%165.74K
34.34%42.71K
34.97%42.15K
31.77%41.53K
51.29%39.35K
35.28%120.55K
47.91%31.79K
44.71%31.23K
44.34%31.52K
Other non cash items
24.30%36.06K
200.48%90.31K
-95.51%3.28K
0.00%29.01K
0.00%29.01K
113.13%29.01K
-107.07%-89.88K
-22.29%73.09K
-92.28%29.01K
-92.34%29.01K
Change In working capital
-510.09%-475.7K
3,543.42%515.33K
138.48%129.06K
186.66%141.93K
24.23%322.31K
-292.09%-77.97K
-95.64%14.14K
-54.75%-335.4K
-78.55%49.51K
4,358.02%259.44K
-Change in receivables
---15.7K
70.00%-3.3K
-31.03%20K
50.69%-14.3K
---9K
--0
-191.67%-11K
866.67%29K
-514.29%-29K
--0
-Change in prepaid assets
13.19%-60.14K
-20.86%57.85K
394.20%20.7K
320.82%77.63K
-82.63%28.8K
33.45%-69.28K
122.10%73.1K
98.26%-7.04K
-19.12%18.45K
701.37%165.79K
-Change in payables and accrued expense
-1,567.97%-361.08K
421.03%600.1K
144.22%124.77K
26.23%113.94K
173.91%336.8K
-86.64%24.6K
-84.53%115.18K
-233.78%-282.18K
-60.19%90.26K
536.97%122.96K
-Change in other current liabilities
-16.50%-38.78K
14.59%-139.33K
51.58%-36.41K
-17.03%-35.34K
-17.03%-34.3K
-17.03%-33.29K
-61.21%-163.13K
-184.36%-75.19K
-17.65%-30.19K
40.29%-29.31K
Cash from discontinued investing activities
Operating cash flow
2.58%-2.32M
-8.75%-6.43M
-9.76%-1.77M
18.87%-1.18M
12.10%-1.1M
-49.21%-2.38M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
-68.65%-1.25M
Investing cash flow
Cash flow from continuing investing activities
-294.08%-4.93M
124.27%3.25M
103.10%100.67K
99.77%-23.06K
561.43%635.26K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
-9.91M
-137.67K
Net PPE purchase and sale
--0
35.51%-171.04K
-64.45%-70.02K
-148.56%-11.95K
78.90%-29.05K
45.22%-60.02K
-765.10%-265.22K
-38.89%-42.58K
--24.61K
---137.67K
Net intangibles purchase and sale
----
--0
----
----
----
----
---175K
----
----
----
Net investment purchase and sale
-289.60%-4.93M
126.41%3.42M
105.64%170.69K
99.89%-11.11K
--664.31K
--2.6M
---12.96M
---3.03M
---9.93M
--0
Cash from discontinued investing activities
Investing cash flow
-294.08%-4.93M
124.27%3.25M
103.10%100.67K
99.77%-23.06K
561.43%635.26K
2,417.33%2.54M
-43,607.53%-13.4M
-10,480.11%-3.24M
---9.91M
---137.67K
Financing cash flow
Cash flow from continuing financing activities
7.52M
2.35M
83.07K
1.85M
411.7K
0
0
0
0
Net common stock issuance
----
--2.35M
--83.07K
--1.85M
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
--7.53M
----
----
----
----
--0
----
----
----
----
Net other financing activities
---9.54K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--7.52M
--2.35M
--83.07K
--1.85M
--411.7K
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-47.25%884.38K
-91.85%1.71M
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-92.03%1.68M
586.11%21.03M
481.84%6.57M
919.49%17.93M
672.62%19.32M
Current changes in cash
70.55%272.7K
95.71%-829.4K
67.29%-1.59M
105.75%653.22K
96.20%-52.82K
109.38%159.89K
-207.52%-19.31M
-124.42%-4.86M
-1,705.09%-11.36M
-87.21%-1.39M
End cash Position
-36.99%1.16M
-48.40%884.38K
-48.40%884.38K
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-91.85%1.71M
-91.85%1.71M
481.84%6.57M
919.49%17.93M
Free cash flow
4.98%-2.32M
-3.90%-6.6M
-0.56%-1.84M
16.63%-1.19M
18.72%-1.13M
-43.13%-2.44M
-89.06%-6.35M
-55.93%-1.83M
-126.74%-1.43M
-87.21%-1.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.58%-2.32M-8.75%-6.43M-9.76%-1.77M18.87%-1.18M12.10%-1.1M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M-68.65%-1.25M
Net income from continuing operations 69.00%-2.22M21.21%-10.42M26.77%1.17M37.16%-2.93M68.08%-1.49M-48.93%-7.17M70.16%-13.22M104.53%924.92K-11.27%-4.66M-15.08%-4.68M
Operating gains losses -221.17%-1.73M14.61%-4.57M--------------1.42M-133.06%-5.35M------------
Depreciation and amortization 8.54%42.71K37.49%165.74K34.34%42.71K34.97%42.15K31.77%41.53K51.29%39.35K35.28%120.55K47.91%31.79K44.71%31.23K44.34%31.52K
Other non cash items 24.30%36.06K200.48%90.31K-95.51%3.28K0.00%29.01K0.00%29.01K113.13%29.01K-107.07%-89.88K-22.29%73.09K-92.28%29.01K-92.34%29.01K
Change In working capital -510.09%-475.7K3,543.42%515.33K138.48%129.06K186.66%141.93K24.23%322.31K-292.09%-77.97K-95.64%14.14K-54.75%-335.4K-78.55%49.51K4,358.02%259.44K
-Change in receivables ---15.7K70.00%-3.3K-31.03%20K50.69%-14.3K---9K--0-191.67%-11K866.67%29K-514.29%-29K--0
-Change in prepaid assets 13.19%-60.14K-20.86%57.85K394.20%20.7K320.82%77.63K-82.63%28.8K33.45%-69.28K122.10%73.1K98.26%-7.04K-19.12%18.45K701.37%165.79K
-Change in payables and accrued expense -1,567.97%-361.08K421.03%600.1K144.22%124.77K26.23%113.94K173.91%336.8K-86.64%24.6K-84.53%115.18K-233.78%-282.18K-60.19%90.26K536.97%122.96K
-Change in other current liabilities -16.50%-38.78K14.59%-139.33K51.58%-36.41K-17.03%-35.34K-17.03%-34.3K-17.03%-33.29K-61.21%-163.13K-184.36%-75.19K-17.65%-30.19K40.29%-29.31K
Cash from discontinued investing activities
Operating cash flow 2.58%-2.32M-8.75%-6.43M-9.76%-1.77M18.87%-1.18M12.10%-1.1M-49.21%-2.38M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M-68.65%-1.25M
Investing cash flow
Cash flow from continuing investing activities -294.08%-4.93M124.27%3.25M103.10%100.67K99.77%-23.06K561.43%635.26K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M-9.91M-137.67K
Net PPE purchase and sale --035.51%-171.04K-64.45%-70.02K-148.56%-11.95K78.90%-29.05K45.22%-60.02K-765.10%-265.22K-38.89%-42.58K--24.61K---137.67K
Net intangibles purchase and sale ------0-------------------175K------------
Net investment purchase and sale -289.60%-4.93M126.41%3.42M105.64%170.69K99.89%-11.11K--664.31K--2.6M---12.96M---3.03M---9.93M--0
Cash from discontinued investing activities
Investing cash flow -294.08%-4.93M124.27%3.25M103.10%100.67K99.77%-23.06K561.43%635.26K2,417.33%2.54M-43,607.53%-13.4M-10,480.11%-3.24M---9.91M---137.67K
Financing cash flow
Cash flow from continuing financing activities 7.52M2.35M83.07K1.85M411.7K0000
Net common stock issuance ------2.35M--83.07K--1.85M----------0--0--0----
Proceeds from stock option exercised by employees --7.53M------------------0----------------
Net other financing activities ---9.54K------------------------------------
Cash from discontinued financing activities
Financing cash flow --7.52M--2.35M--83.07K--1.85M--411.7K--0--0--0--0--0
Net cash flow
Beginning cash position -47.25%884.38K-91.85%1.71M-62.93%2.44M-90.05%1.78M-90.50%1.84M-92.03%1.68M586.11%21.03M481.84%6.57M919.49%17.93M672.62%19.32M
Current changes in cash 70.55%272.7K95.71%-829.4K67.29%-1.59M105.75%653.22K96.20%-52.82K109.38%159.89K-207.52%-19.31M-124.42%-4.86M-1,705.09%-11.36M-87.21%-1.39M
End cash Position -36.99%1.16M-48.40%884.38K-48.40%884.38K-62.93%2.44M-90.05%1.78M-90.50%1.84M-91.85%1.71M-91.85%1.71M481.84%6.57M919.49%17.93M
Free cash flow 4.98%-2.32M-3.90%-6.6M-0.56%-1.84M16.63%-1.19M18.72%-1.13M-43.13%-2.44M-89.06%-6.35M-55.93%-1.83M-126.74%-1.43M-87.21%-1.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg